Genmab — December 2024

[JKY_VH]

Jeg kan godt leve med en kursstigning på 10% resten af året og god morgen:-)

[Riis7]

Tænker deres kursmål er 12 mån og ikke 1 mån;-)

[JKY_VH]

Det tænker jeg også Riis:-)

[E_L]

maybe it is coincidence, but it seems JP Morgen needs to stay within a ~10% range of the current price with their targets since they started downgrading:

[E_L]

may23, target 3200 market 2880 =~11%,
dec23, target 2500 market 2200 =~14%,
aug24 target 2050 market 1850 =~11%,
dec24 target 1700 market 1551 =~10%,

[Riis7]

Maybe AI is making it;-)

[E_L]

[JKY_VH]

Ja, det ligner kunstig intelligens. Jeg foretrækker den ægte vare:-)

[bikube]

1702

[bikube]

aktier til bestyrelsen.

[E_L]

Novo Nordisk to present new data from sickle cell disease and haemophilia trials at the 66th American Society of Hematology (ASH) annual meeting / Mim8 https://www.globenewswire.com/news-release/2024/12/03/2990557/0/en/Novo-Nordisk-to-present-new-data-from-sickle-cell-disease-and-haemophilia-trials-at-the-66th-American-Society-of-Hematology-ASH-annual-meeting.html

[E_L]

the GEN1042 trial in combination with radiotherapy / pembrolizumab set to Active, not recruiting - curious if we can get some info on that soonish https://clinicaltrials.gov/study/NCT05491317

[E_L]

the last push upward went from 1515.5 to 1652 = 136.5dkk. This stint went from 1431 to 1567.5 = 136.5dkk.

[transalp]

Go morgen..

[E_L]

Scancell Announces Genmab Exercises Option to a Second Commercial License Agreement https://www.investegate.co.uk/announcement/rns/scancell-holdings--sclp/second-commercial-license-agreement-with-genmab-/8588688

[E_L]

‘As bispecific antibodies change DLBCL treatment paradigm, Epkinly draws attention’
https://www.koreabiomed.com/news/articleView.html?idxno=25928

[E_L]

Genmab expands its pipeline with $630m Scancell deal https://pharmaphorum.com/news/genmab-expands-its-pipeline-630m-scancell-deal

[Darvin]

Hej E L og andre. Trist at der er blevet så forholdsvist stille i Genmab chatten. Selv skriver jeg heller ikk som tidligere, men pyt med det. E L - du er mere end guld værd, og ikke kun “værdsat”. Håber virkelig du holder ved. Ligesom Solsen, Bulder og flere andre. Ingen flere nævnt desværre, men heller INGEN glemt. Håber virkelig både Genmab (aktien) og vi andre får gejsten igen. NB! Er selv i den grad fortsat i og omkring Genmab, men trist at positivt afkast kun hentes i spekulative dispositio

[Solsen]

EL er uvurderlig. Vi står overfor ASH og efterfølgende et Genmab event. Så stay tuned.

[Darvin]

Undskyld - den med at ingen var glemt kunne misforståes. Jeg mente naturligvis at der var andre super skribenter end de nævnte. Ville blot ikke remse op. Undskyld hvis det blev tolket anderledes